BNN.DE XETRA
BRAIN Biotech AG
1W: +3.6%
1M: +8.2%
3M: +1.8%
YTD: +26.8%
1Y: +31.4%
3Y: -35.8%
5Y: -72.1%
€2.89 ($3.23)
+0.04 (+1.40%)
Weekly Expected Move ±7.5%
€2
€3
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$9M
-157.7% ▼
Capital Expenditures
$2M
+11.5% ▲
5Y CAGR: -11.7%
Free Cash Flow
-$11M
-102.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$21M
-196.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$6M | -$8M | -$11M | -$12M |
| Depreciation & Amort. | $4M | $4M | $5M | $5M | $5M |
| Stock-Based Comp. | $989K | $1M | $0 | $0 | $0 |
| Change in Working Capital | $1M | $4M | $139K | $2M | -$5M |
| Other Non-Cash Items | -$6M | -$4M | -$732K | $884K | $2M |
| Operating Cash Flow | -$4M | -$1M | -$4M | -$4M | -$9M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$6M | -$3M | -$2M | -$2M |
| Acquisitions (Net) | -$1M | -$5M | $3M | $0 | $37K |
| Investment Purchases | -$564K | -$1M | $0 | $0 | $0 |
| Investment Sales | $564K | $1M | $6K | $0 | $0 |
| Other Investing | $82K | -$1M | $249K | -$137K | $12K |
| Investing Cash Flow | -$2M | -$13M | $562K | -$2M | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$2M | $10M | $26M | -$8M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$5M | $0 | -$10M | $0 | -$2M |
| Financing Cash Flow | $12M | -$2M | $459K | $27M | -$10M |
| Net Change in Cash | $6M | -$16M | -$3M | $22M | -$21M |
| Cash End of Period | $25M | $8M | $5M | $27M | $6M |
| Free Cash Flow | -$5M | -$8M | -$7M | -$5M | -$11M |